Skip to main content
Log in

Proliferating cell nuclear antigen expression in central nervous system neoplasms

  • Original Articles
  • Published:
Virchows Archiv A Aims and scope Submit manuscript

Summary

Proliferating cell nuclear antigen (PCNA) is a cell-cycle-regulated protein, which can be demonstrated in routinely fixed specimens. Studies on various tissues, cell cultures and neoplasms have shown that PCNA labelling index (LI) correlates with flow cytometry, tritiated thymidine LI, bromodeoxyuridine (BrdU) incorporation and Ki67 LI. PCNA LI may have prognostic value in various neoplasms. The present study concerns PCNA immunostaining in a series of neuroglial tumours. We demonstrate that there is a relation between PCNA LI and histological grade, and between PCNA LI and reported thymidine LI, BrdU LI and Ki67 LI. Pleomorphic xanthoastrocytomas and lowgrade astrocytomas had the lowest LI, whereas metastases of small cell lung cancer and medulloblastomas had the highest LI. Glioblastomas sometimes showed a certain degree of intratumoral heterogeneity of distribution of immunostained cells. Intratumoral heterogeneity underscores the critical importance of representative sampling of central nervous system neoplasms for kinetic studies. As expected, PCNA LI are somewhat higher than tritiated thymidine LI, BrdU LI and Ki67 LI because PCNA is a marker of G1, S, G2 and M-phases of the cell cycle and not of S-phase only. In addition, because of its long half-life, PCNA may be detected immunohistochemically in cells that have recently left the cell cycle. The immunohistochemical evaluation of PCNA LI is easy to perform on routinely processed material, allowing retrospective studies. PCNA LI may be a useful tool in grading gliomas. However, its prognostic value must be validated by comparing PCNA LI with the follow-up of the neoplasms, and possibly with the responsiveness to anti-proliferative therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allegranza A, Ferraresi S, Bruzzone M, Giombini S (1991) Cerebromeningeal pleomorphic xanthoastrocytoma. Report of three cases: clinical, radiological and pathological features. Neurosurg Rev 4:43–49

    Google Scholar 

  • Barbareschi M, Doglioni C, Girlando S, Arrigoni GL, Mauri FA, Dalla Palma P (1991) PCNA, p53 protein and Rb product expression in neuroendocrine lung neoplasms. Path Res Pract 187:653 (Abstract)

    Google Scholar 

  • Battersby S, Anderson TJ (1990) Correlation of proliferative activity in breast tissue using PCNA/cyclin. Hum Pathol 21:781

    Google Scholar 

  • Boecker D-K, Stark H-J (1988) The proliferative rate of intracranial tumours as defined by the monoclonal antibody Ki67. Application of the method to paraffin embedded specimens. Neurosurg Rev 11:267–272

    Google Scholar 

  • Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17:489–503

    Google Scholar 

  • Burger PC, Vogel FS, Green SB, Strike TA (1985) Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106–1111

    Google Scholar 

  • Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki67 in the identification of proliferating cells. Application to surgical neuropathology. Am J Surg Pathol 10:611–617

    Google Scholar 

  • Burger PC, Scheithauer BW, Vogel FS (1991) Surgical pathology of the nervous system and its coverings. Churchill Livingstone, New York

    Google Scholar 

  • Coltrera MC, Gown AM (1991) PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem 39:23–30

    Google Scholar 

  • Dawson AE, Norton JA, Weinberg DS (1990) Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry. Am J Pathol 136:1115–1124

    Google Scholar 

  • Garcia RL, Coltrera MD, Gown AM (1989) Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Am J Pathol 134:733–739

    Google Scholar 

  • Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H (1987) Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 74:179–182

    Google Scholar 

  • Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294

    Google Scholar 

  • Hara A, Hirayama H, Sakai N, Yamada H, Tanaka T, Mori H (1990) Correlation between nucleolar organizer region staining and Ki67 immunostaining in human gliomas. Surg Neurol 33:320–324

    Google Scholar 

  • Hoshino T, Wilson CB (1979) Cell kinetic analysis of human malignant brain tumours (gliomas). Cancer 44:956–962

    Google Scholar 

  • Hoshino T, Kobayshi S, Townsend JJ, Wilson CB (1985) A cell kinetic study on medulloblastoma. Cancer 55:1711–1713

    Google Scholar 

  • Hoshino T, Nagashima T, Murovic JA, Wilson CB, Edwards MSB, Gutin PH, Davis RL, Dearmond SJ (1986) In situ cell kinetics studies on human neuroectodermal tumours with bromodeoxyuridine labelling. J Neurosurg 64:453–459

    Google Scholar 

  • Hoshino T, Rodriguez LA, Cho KC, Lee KS, Wilson CB, Edwards MSB, Levin VA, Davis RL (1988) Prognostic implications of the proliferative potential of low-grade astrocytomas. J Neurosurg 69:839–842

    Google Scholar 

  • Hoshino T, Prados M, Wilson CB, Gi Cho K, Lee KS, Davis RL (1989) Prognostic implications of the bromodeoxyuridine labelling index of human gliomas. J Neurosurg 71:335–341

    Google Scholar 

  • Iggo R, Gatter K, Bartek J, Lane D, Harris AL (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335:675–679

    Google Scholar 

  • Landolt AM, Shibata T, Kleihues P (1987) Growth rate of pituitary adenomas. J Neurosurg 67:803–806

    Google Scholar 

  • Levison DA, Hall PA, Woods AL, Yu C, Barnes DM, Wasseem N, Lane DP (1990) Evaluation of PCNA (proliferating cell nuclear antigen) immunostaining as a marker of cell proliferation in formalin-fixed paraffin-embedded tissues. J Pathol 161:340

    Google Scholar 

  • Loda M, Giangaspero F, Badiali M, Capodieci P, Pession A (1991) p53 gene expression in medulloblastoma by quantitative polymerase chain reaction. Diagn Mol Pathol (in press)

  • Mercer EW, Shield MT, Amin M, Sauve GJ, Appella E, Romano JW, Ullrich ST (1991) Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 87:6166–6170

    Google Scholar 

  • Nakashima T, Dearmond SJ, Murovic J, Hoshino T (1985) Immunocytochemical demonstration of S-phase cells by antibromodeoxyuridine monoclonal antibody in human brain tumor tissues. Acta Neuropathol (Berl) 67:155–159

    Google Scholar 

  • Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K (1989) Flow cytometric DNA analysis and immunohistochemical measurement of Ki67 and BrdU labeling indices in human brain tumors. J Neurosurg 70:379–384

    Google Scholar 

  • Ogata K, Ogata Y, Takasaki Y, Tan EM (1987) Epitopes on proliferating cell nuclear antigen recognized by human lupus autoantibody and murine monoclonal antibody. J Immunol 139:2942–2946

    Google Scholar 

  • Ostertag CB, Volk B, Shibata T, Burger P, Kleihues P (1987) The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours. Acta Neurochir (Wien) 89:117–121

    Google Scholar 

  • Patsouris E, Stocker U, Kallmayer V, Keiditsch E, Mehraein P (1988) Relationship between Ki67 positive cells, growth rate and histological type of human intracranial tumors. Anticancer Res 8:537–544

    Google Scholar 

  • Plate KH, Rueschoff J, Behnke J, Mennel HD (1989) Correlation of silver stained nucleolar organizer regions (AgNOR) with malignancy grade and Ki67 labelling index in smear preparations of human CNS neoplasms. Clin Neuropathol 8:245–246

    Google Scholar 

  • Plate KH, Rueschoff J, Behnke J, Mennel HD (1990) Proliferative potential of human brain tumors as assessed by nucleolar organizer regions (AgNORs) and Ki67 immunoreactivity. Acta Neurochir (Wien) 104:103–109

    Google Scholar 

  • Prelich G, Stillman B (1988) Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 53:117–126

    Google Scholar 

  • Roggendorf W, Schuster T, Pfeiffer J (1987) Proliferative potential of meningiomas determined with the monoclonal antibody Ki67. Acta Neuropathol (Berl) 73:361–364

    Google Scholar 

  • Shibata T, Burger PC (1987) The use of monoclonal antibody Ki67 in determination of the growth fraction in pediatric brain tumours. Childs Nerv Syst 3:364–367

    Google Scholar 

  • Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF (1989) p53: a frequent target for genetic abnormalities in lung cancer. Science 246:491–494

    Google Scholar 

  • Tan CK, Castillo C, So AG, Downey KM (1986) An auxiliary protein for DNA polymerase delta from fetal calf thymus. J Biol Chem 261:1231–1236

    Google Scholar 

  • Tsutsumi Y, Hori S, Onoda M (1990) DNA polymerase-alpha. Am J Clin Pathol 93:643–650

    Google Scholar 

  • Tubiana M, Courdi A (1989) Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long term survival. Radiother Oncol 15:1–18

    Google Scholar 

  • Waseem NH, Lane DP (1990) Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci 96:121–129

    Google Scholar 

  • Wilson RG, Smith AN, Bird CC (1990) Immunohistochemical detection of abnormal cell proliferation in colonic mucosa of subjects with polyps. J Clin Pathol 43:744–747

    Google Scholar 

  • Woods AL, Hanby AM, Hall PA, Wasseem N, Lane DP, Levison D (1990) The prognostic value of PCNA (proliferating cell nuclear antigen) immunostaining in gastro-intestinal lymphomas. J Pathol 161:342

    Google Scholar 

  • Zuber P, Hamou MF, Tribolet N de (1988) Identification of proliferating cells in human gliomas using the monoclonal antibody Ki67. Neurosurgery 22:364–368

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allegranza, A., Girlando, S., Arrigoni, G.L. et al. Proliferating cell nuclear antigen expression in central nervous system neoplasms. Vichows Archiv A Pathol Anat 419, 417–423 (1991). https://doi.org/10.1007/BF01605076

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01605076

Key words

Navigation